CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Batista, Mariana D ^a,b   Tincati, Camilla ^a   Milush, Jeffrey M ^a   Ho, Emily L ^a,f   Ndhlovu, Lishomwa C ^a,g   York, Vanessa A ^a   Kallas, Esper G ^b   Kalil, Jorge ^b   Keating, Sheila M ^a,c   Norris, Philip J ^a,c   Chang, David ^d   Unemori, Patrick ^e   Leslie, Kieron S ^e   Maurer, Toby ^e   Liao, Wilson ^e   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 27; INTERLEUKIN 33; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PSORIASIS; SKIN BIOPSY; T LYMPHOCYTE;

ADULT; ANTIGENS, CD57; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SKIN; T-LYMPHOCYTES;

EID: 84874533147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052144     Document Type: Article

References (37)

1. Nestle FO, Kaplan DH, Barker J, (2009) Psoriasis. N Engl J Med 361: 496-509.
2. Sabat R, Philipp S, Hoflich C, Kreutzer S, Wallace E, et al. (2007) Immunopathogenesis of psoriasis. Exp Dermatol 16: 779-798.
3. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128: 1207-1211.
4. Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suarez-Farinas M, et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159: 1092-1102.
5. Di Cesare A, Di Meglio P, Nestle FO, (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129: 1339-1350.
6. Mak RK, Hundhausen C, Nestle FO, (2009) Progress in understanding the immunopathogenesis of psoriasis. Actas Dermosifiliogr 100 Suppl 2: 2-13.
7. Ortega C, Fernandez AS, Carrillo JM, Romero P, Molina IJ, et al. (2009) IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J Leukoc Biol 86: 435-443.
8. Res PC, Piskin G, de Boer OJ, van der Loos CM, Teeling P, et al. (2010) Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One 5: e14108.
9. Evans TG, Kallas EG, Luque AE, Menegus M, McNair C, et al. (1999) Expansion of the CD57 subset of CD8 T cells in HIV-1 infection is related to CMV serostatus. AIDS 13: 1139-1141.
10. Arai K, Yamamura S, Seki S, Hanyu T, Takahashi HE, et al. (1998) Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti-inflammatory role. Clin Exp Immunol 111: 345-352.
11. Iking-Konert C, Vogl T, Prior B, Bleck E, Ostendorf B, et al. (2009) Expression of CD57 on CD8+ T lymphocytes of patients with Wegener's granulomatosis and microscopic polyangiitis: evidence for continuous activation of CD8+ cells. Clin Exp Rheumatol 27: S19-24.
12. Focosi D, Bestagno M, Burrone O, Petrini M, (2010) CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 87: 107-116.
13. Simpson RJ, Cosgrove C, Ingram LA, Florida-James GD, Whyte GP, et al. (2008) Senescent T-lymphocytes are mobilised into the peripheral blood compartment in young and older humans after exhaustive exercise. Brain Behav Immun 22: 544-551.
14. Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, et al. (2000) Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev 121: 77-88.
15. Le Priol Y, Puthier D, Lecureuil C, Combadiere C, Debre P, et al. (2006) High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals. J Immunol 177: 5145-5154.
16. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, et al. (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101: 2711-2720.
17. Shibata S, Tada Y, Kanda N, Nashiro K, Kamata M, et al. Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol 130: 1034-1039.
18. Theoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A 107: 4448-4453.
19. Caruso R, Botti E, Sarra M, Esposito M, Stolfi C, et al. (2009) Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med 15: 1013-1015.
20. Chattopadhyay PK, Betts MR, Price DA, Gostick E, Horton H, et al. (2009) The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J Leukoc Biol 85: 88-97.
21. Palmer BE, Blyveis N, Fontenot AP, Wilson CC, (2005) Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 175: 8415-8423.
22. Cameron AL, Kirby B, Fei W, Griffiths CE, (2002) Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res 294: 363-369.
23. Plant D, Young HS, Watson RE, Worthington J, Griffiths CE, (2006) The CX3CL1-CX3CR1 system and psoriasis. Exp Dermatol 15: 900-903.
24. Clark RA, (2010) Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 130: 362-370.
25. Clark RA, (2011) Gone but not forgotten: lesional memory in psoriatic skin. J Invest Dermatol 131: 283-285.
26. Suarez-Farinas M, Fuentes-Duculan J, Lowes MA, Krueger JG, (2011) Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol 131: 391-400.
27. Suarez-Farinas M, Tintle SJ, Shemer A, Chiricozzi A, Nograles K, et al. (2011) Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 127: 954-964 e951-954.
28. Gudjonsson JE, Ding J, Li X, Nair RP, Tejasvi T, et al. (2009) Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol 129: 2795-2804.
29. Stritesky GL, Yeh N, Kaplan MH, (2008) IL-23 promotes maintenance but not commitment to the Th17 lineage. J Immunol 181: 5948-5955.
30. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD, (1998) Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 111: 645-649.
31. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271-2279.
32. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957.
33. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651.
34. Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, et al. (2009) IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123: 1244-1252 e1242.
35. Zenewicz LA, Flavell RA, (2011) Recent advances in IL-22 biology. Int Immunol 23: 159-163.
36. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36: 1309-1323.
37. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, et al. (2005) IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174: 3695-3702.